Oruka Therapeutics Inc. Common Stock vs Cactus Inc. Class A Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Cactus Inc. Class A Common Stock trades at $62.37 (market cap $5.14B). The key difference: Oruka Therapeutics Inc. Common Stock and Cactus Inc. Class A Common Stock are close in size by market cap, and Cactus Inc. Class A Common Stock pays a 0.94% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Cactus Inc. Class A Common Stock for 0 Days on average.
| ORKA | WHD | |
|---|---|---|
Market Cap | $5.18B | $5.14B |
Volume | 490,798 | 634,348 |
Sector | Health | Energy |
52-Week High | $113.08 | $73.73 |
52-Week Low | $26.19 | $35.26 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $4.83B |
Dividend Yield | — | 0.94% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Cactus Inc. designs, manufactures, and rents wellhead and pressure control equipment for oil and gas drilling, completion, and production, operating under the Cactus Wellhead brand.
Read more on WHD →